Edition:
United States

Proteon Therapeutics Inc (PRTO.A)

PRTO.A on American Stock Exchange

0.51USD
1 Apr 2019
Change (% chg)

-- (--)
Prev Close
$0.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,687
52-wk High
$3.74
52-wk Low
$0.48

About

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly... (more)

Overall

Beta: --
Market Cap(Mil.): $46.69
Shares Outstanding(Mil.): 17.62
Dividend: --
Yield (%): --

Financials

  PRTO.A Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.56 -- --
ROI: -65.10 8.91 13.83
ROE: -65.10 10.06 15.25

Earnings vs. Estimates